SCHEMBL4866308

SCHEMBL4866308

NC(=O)CC1(c2ccccc2)CCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.58
LMNA P02545 6/20 0.53
HSD11B1 P28845 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
AKR1C1 Q04828 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HSD17B10 Q99714 1/20 0.48
SLC6A4 P31645 3/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A3 Q01959 2/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17761202 0.98 DPP4 (0.56) DPP4LMNAHSD11B1L3MBTL1SMN1; SMN2
SCHEMBL6208549 0.90 SLC6A4 (0.61) DPP4LMNAHSD11B1L3MBTL1SMN1; SMN2
SCHEMBL6208426 0.89 SLC6A4 (0.64) DPP4LMNAHSD11B1L3MBTL1SMN1; SMN2
SCHEMBL977926 0.85 HSD11B1 (0.69) DPP4LMNAHSD11B1L3MBTL1SMN1; SMN2
SCHEMBL4760898 0.84 TACR1 (0.49) DPP4HSD11B1SLC6A4SLC6A2SLC6A3
SCHEMBL5365797 0.83 HSD11B1 (0.72) DPP4LMNAHSD11B1L3MBTL1SMN1; SMN2
Hydrochloric Acid SCHEMBL7462887 0.83 TACR1 (0.48) DPP4HSD11B1SLC6A4SLC6A2SLC6A3
SCHEMBL12836588 0.82 SLC6A4 (0.59) HSD11B1SLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL15873720 0.82 HSD11B1 (0.49) DPP4HSD11B1L3MBTL1SMN1; SMN2SLC6A4
SCHEMBL17761311 0.82 HSD11B1 (0.71) HSD11B1SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153917-A1 Sigma Receptor Ligands UCB PHARMA, S.A. (BE) 2008-06-26 US disclosed
US-20080153917-A1 Sigma Receptor Ligands UCB PHARMA, S.A. (BE) 2008-06-26 US disclosed
EP-1797036-A1 SIGMA RECEPTOR LIGANDS UCB Pharma, S.A. (BE) 2007-06-20 EP disclosed
EP-1797036-A1 SIGMA RECEPTOR LIGANDS UCB Pharma, S.A. (BE) 2007-06-20 EP disclosed
WO-2006027252-A1 SIGMA RECEPTOR LIGANDS UCB PHARMA, SA (BE) 2006-03-16 WO disclosed
WO-2006027252-A1 SIGMA RECEPTOR LIGANDS UCB PHARMA, SA (BE) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153917-A1 Sigma Receptor Ligands SIGMAR1, TMEM97, OPRL1 DPP4 1897/4885LMNA 2072/4885HSD11B1 2537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.